Acuta Capital Partners, Llc Portfolio Stock Holdings
Acuta Capital Partners, Llc disclosed 26 stock positions valued at approximately $140.6 million in its latest SEC 13F filing. The largest holdings include PRAXIS PRECISION MEDICINES I, TERNS PHARMACEUTICALS INC, and WHITEHAWK THERAPEUTICS INC. The filing reflects positions held as of March 31, 2026 and was filed on May 15, 2026.
- Report Period
- March 31, 2026
- No. of Stocks
- 26
- Portfolio Value
- $140.6M
Holdings by Sector
Acuta Capital Partners, Llc Portfolio Holdings in Q1 2026
20 holdings in the latest reporting period.
Page 1 of 1
| Company | Symbol | Sector | Portfolio % | Shares | Change (Shares) | Change % | Value |
|---|---|---|---|---|---|---|---|
| PRAXIS PRECISION MEDICINES I | PRAX | Healthcare | 19.46% | 84,901 | +1,865 | +2.25% | $27,354,253 |
| TERNS PHARMACEUTICALS INC | TERN | Healthcare | 18.59% | 495,772 | -141,323 | -22.18% | $26,137,100 |
| WHITEHAWK THERAPEUTICS INC | AADI | Healthcare | 8.37% | 3,410,402 | - | - | $11,765,887 |
| TANGO THERAPEUTICS INC | TNGX | Healthcare | 6.57% | 441,831 | +159,099 | +56.27% | $9,243,105 |
| ERASCA INC | ERAS | Healthcare | 4.08% | 354,575 | +354,575 | +100.00% | $5,737,024 |
| SURROZEN INC | SRZN | Healthcare | 3.58% | 172,847 | -5,568 | -3.12% | $5,035,033 |
| OCULAR THERAPEUTIX INC | OCUL | Healthcare | 3.57% | 592,108 | -460,887 | -43.77% | $5,015,155 |
| COMPASS THERAPEUTICS INC | CMPX | Healthcare | 3.19% | 849,076 | -244,224 | -22.34% | $4,491,612 |
| MINERVA NEUROSCIENCES | NERV | Healthcare | 3.04% | 709,500 | - | - | $4,274,738 |
| MOONLAKE IMMUNOTHERAPEUTICS | MLTX | Healthcare | 2.54% | 191,760 | +132,480 | +223.48% | $3,574,406 |
| ARGEN SE - ADR | ARGX | Healthcare | 2.44% | 4,690 | -161 | -3.32% | $3,424,873 |
| OCULIS HOLDING AG | H5870P102 | Other | 1.86% | 98,339 | -3,438 | -3.38% | $2,614,834 |
| REVOLUTION MEDICINES INC | RVMD | Healthcare | 1.80% | 26,069 | +17,658 | +209.94% | $2,535,210 |
| AMYLYX PHARMACEUTICALS INC | AMLX | Healthcare | 1.49% | 151,067 | -182,191 | -54.67% | $2,099,831 |
| TAYSHA GENE THERAPIES INC | TSHA | Healthcare | 1.40% | 439,464 | -15,363 | -3.38% | $1,964,404 |
| IDEAYA BIOSCIENCES INC | IDYA | Healthcare | 1.14% | 48,234 | +48,234 | +100.00% | $1,607,157 |
| DESIGN THERAPEUTICS INC | DSGN | Healthcare | 1.10% | 145,900 | -5,006 | -3.32% | $1,552,376 |
| UNITED THERAPEUTICS CORP | UTHR | Healthcare | 0.94% | 2,224 | -72 | -3.14% | $1,318,788 |
| ENTRADA THERAPEUTICS INC | TRDA | Healthcare | 0.80% | 89,358 | +89,358 | +100.00% | $1,127,698 |
| AVALO THERAPEUTICS INC | AVTX | Healthcare | 0.65% | 60,808 | +60,808 | +100.00% | $907,863 |
Acuta Capital Partners, Llc Options Holdings in Q1 2026
1 options positions in the latest reporting period.
Page 1 of 1
| Quarter | Symbol | Company | Option | Contracts | Notional Value |
|---|---|---|---|---|---|
| Q1 2026 | IDYA | IDEAYA Biosciences, Inc. | CALL | 350 | $1,166,200 |
Notional value represents the total exposure of the options position.